0.665 -0.027 (-3.96%) | 09-19 13:46 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.92 | 1-year : | 1.09 |
Resists | First : | 0.79 | Second : | 0.93 |
Pivot price | 0.78 | |||
Supports | First : | 0.55 | Second : | 0.45 |
MAs | MA(5) : | 0.73 | MA(20) : | 0.73 |
MA(100) : | 1.37 | MA(250) : | 0 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 36.5 | D(3) : | 47.3 |
RSI | RSI(14): 40.9 | |||
52-week | High : | 6.09 | Low : | 0.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AMIX ] has closed above bottom band by 20.1%. Bollinger Bands are 57.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.72 - 0.73 | 0.73 - 0.73 |
Low: | 0.66 - 0.67 | 0.67 - 0.68 |
Close: | 0.68 - 0.69 | 0.69 - 0.7 |
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Mon, 15 Jul 2024
Surge In Autonomix Medical (AMIX) Stock Amid Patent Licensing Initiative - Catching News
Mon, 15 Jul 2024
Autonomix Medical Secures License, Shares for Pain Tech - TipRanks
Mon, 15 Jul 2024
Autonomix Medical Inc (AMIX) Soars Over 100% Following Strategic Licensing Agreement - BP Journal
Mon, 15 Jul 2024
What Happened With Autonomix Medical Stock Today? - Benzinga
Mon, 26 Feb 2024
AMIX - Autonomix Medical, Inc. Latest Stock News & Market Updates - StockTitan
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 23 (M) |
Shares Float | 13 (M) |
Held by Insiders | 41.6 (%) |
Held by Institutions | 0.4 (%) |
Shares Short | 198 (K) |
Shares Short P.Month | 102 (K) |
EPS | -0.9 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.28 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -123.6 % |
Return on Equity (ttm) | -581.9 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -8 (M) |
Levered Free Cash Flow | -5 (M) |
PE Ratio | -0.74 |
PEG Ratio | 0 |
Price to Book value | 2.37 |
Price to Sales | 0 |
Price to Cash Flow | -1.96 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |